As artificial intelligence (AI) reshapes industries, its transformative potential comes with a complex web of regulatory ...

Jessica Copeland and Marc Krawiec explain that despite early provisions in the One Big Beautiful Bill Act to block state ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

As AI, model-based systems engineering and digital thread strategies evolve, they're transforming how organizations define ...

A terrific indication of AI’s promise is the 2024 Nobel Prize in chemistry, winners of which used AI to “crack the code” of ...

U.S. President Donald Trump is slated to deliver a message outlining his vision for America's role in the development of ...

Google, Meta, and CoreWeave lead an expected $90 billion wave of AI and energy investments in Pennsylvania, marking a shift ...

Despite the growing volume of literature, the authors argue that current research efforts fall short in one crucial respect: ...

Healthcare product development is undergoing a major transformation, driven by technologies like AI, ML, and IoMT. These ...

As technology continues to reshape financial services, regulators and policy setters are embarking on a range of ...

The failure to enact a proposed 10-year moratorium on state AI regulations brings meaningful clarity for employers, according ...

By 2023, the tone had shifted. Venture capital cooled. According to CB Insights, funding for AI drug discovery start-ups ...